Free Trial

Krystal Biotech (KRYS) SEC Filings & 10K Form

Krystal Biotech logo
$166.16 +0.47 (+0.28%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$169.11 +2.95 (+1.78%)
As of 05:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Krystal Biotech SEC Filings

DateFilerForm TypeView
04/28/2025
7:53 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
3:44 PM
Krystal Biotech (Filer)
Form ARS
04/03/2025
3:38 PM
Krystal Biotech (Filer)
Form DEF 14A
03/13/2025
5:04 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
5:06 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:58 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
6:00 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
6:01 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
10:52 AM
Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
6:19 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
6:25 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
6:51 AM
Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
12/18/2024
7:39 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:27 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
5:28 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:22 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2024
7:30 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:00 PM
Krystal Biotech (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/04/2024
7:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
7:05 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2024
11:28 AM
Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/13/2024
4:41 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:44 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:45 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:33 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:33 PM
Krishnan Suma (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:31 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
7:03 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
7:08 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
12:14 PM
Krystal Biotech (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
07/01/2024
6:32 PM
Krystal Biotech (Issuer)
Mason Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:34 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:37 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:21 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:24 PM
Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:29 PM
Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:31 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:33 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:17 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:38 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon’s Terrifying Warning Forces Trump To Take Action (Ad)

Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...

05/20/2024
3:51 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
7:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
7:17 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KRYS) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners